| |
 |
Next-generation sequencing: ready for the clinics?
view |
|
Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.
view |
|
Next-generation sequencing for cancer diagnostics: a practical perspective.
view |
|
Perspectives and Challenges of Emerging Single-Molecule DNA Sequencing Technologies.
view |
|
Induced Pluripotent Stem Cells and Reprogramming: Seeing the Science through the Hype.
view |
|
Whole Genome Transcriptome Analysis.
view |
|
|
Genomics.
Post genome products and services for human, animals, plants and other organisms.
Read more |
| |
Proteomics.
From genome to proteome using reliable robust products and services.
Read more |
| |
Stem Cells and Related Technologies.
Technologies for development of personalized, disease, and patient specific diagnostics and therapeutics.
Read more |
| |
 |
|
|
News
01/05/2013
DNAmicroarray, Inc. presented recent findings on the application of CiPSC methodology for disease modeling and drug toxicity testing at the ISSCR-Roddenberry International Symposium on Cellular Reprogramming Conference in San Francisco, CA. Read more
|
| |
|
| |
|
| |
|
| |
 |
|
|
